News Listing

Filter by
Date
Nov 23, 2017 09:37 AM

Small but mighty: the tiny molecules that regulate cancer ce...

A Garvan-led research team has performed the largest ever study of how ‘microRNAs’ function in cancer cells. Hundreds of these tiny molecules play an important role in whether cancer cells live or die, the researchers fo...

MEDIA RELEASE: Nov 16, 2017 06:46 AM

Pancreatic cancer: Avner Foundation awards major grants to i...

On World Pancreatic Cancer Day, the Avner Pancreatic Cancer Foundation has awarded grants of over $900,000 to Garvan's pancreatic cancer researchers. The grants will support ambitious new research into the 'matrix' surro...

Nov 14, 2017 02:52 PM

Pancreatic cancer: a lucky quirk in Ros’ DNA holds the key t...

In long-term survivors of pancreatic cancer, the immune system sees the cancer as an infectious disease – and so is empowered to attack and destroy tumour cells, according to new research from the US and Australia. This ...

Nov 10, 2017 10:31 AM

Garvan researchers shine across Australia

Garvan congratulates five early career researchers who received awards at two national meetings last week – the annual conference of Australasian Genomic Technologies Association (AGTA), and Epigenetics 2017.

MEDIA RELEASE: Nov 09, 2017 06:02 AM

Long-term survivors of pancreatic cancer have ‘built-in immu...

In long-term survivors of pancreatic cancer, the immune system sees the cancer as an infectious disease – and so is empowered to attack and destroy tumour cells, according to findings published today in Nature. The Austr...

MEDIA RELEASE: Nov 01, 2017 05:54 AM

Breakthrough breast cancer drug targets a major type of panc...

A newly approved breast cancer drug could be highly effective against some forms of pancreatic cancer, including metastatic cancer, Australian researchers have found.

Oct 31, 2017 04:30 PM

‘Connie’s Heart’ raises $110,000 for cancer research

The large-scale artwork ‘Connie’s Heart’, by Marie Ramos, has this week been unveiled at Garvan by Samuel Johnson OAM. Inspired by Connie Johnson and Love Your Sister, the artwork was a year in the making and has raised ...

MEDIA RELEASE: Oct 24, 2017 06:30 AM

DreamLab app speeding up Garvan’s cancer research

The DreamLab app, a distributed smartphone supercomputer, is now available on iOS and Android. Garvan and The Vodafone Foundation are now calling one million Australians to download the app and contribute to Garvan’s can...

Oct 18, 2017 09:47 AM

Leading genomic data projects to drive a new ‘world of knowl...

Garvan researchers are key contributors to three genomic data initiatives selected as key Driver Projects by the Global Alliance for Genomics and Health (GA4GH) in a 5-year vision to fully realise the promise of genomic ...

MEDIA RELEASE: Oct 11, 2017 08:33 AM

Blockchain tech: Garvan partners with E-Nome

Garvan has signed a memorandum of understanding with E-Nome Pty Ltd, an Australian technology startup driving the application of blockchain technology to the secure storage of health records. Together, Garvan and E-Nome ...

Oct 10, 2017 04:49 PM

The importance of returning research results to study partic...

Researchers from Garvan and the Australian Pancreatic Cancer Genome Initiative have explored the feasibility and value of returning the results of genomic research studies to study participants.

MEDIA RELEASE: Oct 06, 2017 05:00 AM

Biosensor mouse lights up health and disease

Garvan researchers have developed a biosensor mouse that gives a real-time readout of the rapidly changing ‘skeleton’ within cells. The researchers have watched cells respond dynamically to their surrounding environment ...

MEDIA RELEASE: Sep 22, 2017 06:42 AM

African prehistory: A long-awaited landscape revealed throug...

The first large-scale study of ancient human DNA from sub-Saharan Africa opens a long-awaited window into the identity of prehistoric populations in the region and how they moved around and replaced one another over the ...

Sep 18, 2017 06:00 PM

Now open: Zero Childhood Cancer program to deliver personali...

The Garvan Institute, with the Lions Clubs International Foundation and the Australian Lions Childhood Cancer Research Foundation, is proud to be a partner in the Zero Childhood Cancer national child cancer personalised ...

Sep 13, 2017 12:00 PM

Dubbo Osteoporosis Epidemiology Study

Take 5000 people, scrutinise for three decades and what do you get? A wholly new understanding of osteoporosis for starters, and the insights keep on coming.

Sep 11, 2017 08:51 AM

Vale Connie Johnson OAM

Vale Constance (Connie) Johnson OAM 1977 – 2017.

MEDIA RELEASE: Sep 10, 2017 07:30 AM

Type 1 diabetes: Releasing the 'insulin handbrake' could mak...

A Garvan-led research team has shown that a new therapeutic approach can enhance insulin secretion by the pancreas, and has the potential to improve islet cell transplants in individuals with type 1 diabetes

MEDIA RELEASE: Sep 07, 2017 10:48 PM

‘Partner in crime’ mutations work together to kickstart lymp...

Australian researchers have uncovered ‘extraordinary cooperation’ between two DNA mutations that are often found together in lymphomas and leukaemias. The findings help us understand how immune cells can ‘go rogue’, beha...

Sep 06, 2017 10:50 AM

Osteoporosis: major study identifies 150 new genetic sites t...

In the largest ever study of its kind, an international research team has identified over 150 new sites in the human genome that are linked to low bone mineral density and to an increased risk of fracture. The findings v...

Aug 31, 2017 01:20 PM

Professor Mark Febbraio: exercise is medicine

Garvan congratulates Professor Mark Febbraio, who has won the 2017 Australian Diabetes Society (ADS) Kellion Award. The award recognises an Australian researcher who has made an outstanding contribution to diabetes resea...

MEDIA RELEASE: Aug 23, 2017 06:00 AM

Ground-breaking trial brings personalised treatments to thos...

Garvan's Genomic Cancer Medicine Program, launched today by The Hon. Brad Hazzard, uses genomic medicine to match therapies, prevention and screening methods with rare cancer patients based on their genetic information.